Esophageal Carcinoma — Trials

Esophageal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

807 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 307
Recruiting: 179
Ph III recruiting: 26
Growth YoY: +33.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 26.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (62)

clinicaltrialsPublishedShowing 51–72 of 72 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04229459	Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.	active not recruiting	Phase 2	12	Baruch BrennerOTHER	1	Jan 14, 2026	clinicaltrials
NCT04028167	Induction FLOT With CROSS CRT for Esophageal Cancer	active not recruiting	Phase 2	40	University of Colorado, DenverOTHER	1	Jan 9, 2026	clinicaltrials